41.05
-0.70
(-1.68%)
As of 11:44:04 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,157,929.00
1,969,081.00
1,759,049.00
1,678,153.00
1,428,933.00
Cost of Revenue
421,352.00
395,707.00
379,610.00
340,649.00
282,186.00
Gross Profit
1,736,577.00
1,573,374.00
1,379,439.00
1,337,504.00
1,146,747.00
Operating Expense
1,430,549.00
1,287,211.00
1,144,002.00
1,118,260.00
807,765.00
Operating Income
306,028.00
286,163.00
235,437.00
219,244.00
338,982.00
Net Non Operating Interest Income Expense
-25,434.00
-19,798.00
112.00
-9,218.00
-2,864.00
Pretax Income
207,945.00
193,716.00
160,372.00
209,736.00
175,477.00
Tax Provision
66,658.00
63,076.00
50,637.00
65,159.00
54,672.00
Net Income Common Stockholders
140,867.00
127,644.00
103,658.00
136,855.00
116,408.00
Diluted NI Available to Com Stockholders
140,867.00
127,644.00
103,658.00
136,855.00
116,408.00
Basic EPS
1.67
1.52
1.23
1.63
1.39
Diluted EPS
1.67
1.52
1.23
1.63
1.39
Basic Average Shares
84,326.41
83,994.00
83,999.00
84,000.00
83,994.00
Diluted Average Shares
83,993.63
83,994.00
83,999.00
84,000.00
83,994.00
Rent Expense Supplemental
--
54,556.00
41,844.00
38,224.00
35,826.00
Total Expenses
1,851,901.00
1,682,918.00
1,523,612.00
1,458,909.00
1,089,951.00
Net Income from Continuing & Discontinued Operation
140,867.00
127,644.00
103,658.00
136,855.00
116,408.00
Normalized Income
194,862.42
181,206.78
158,857.48
136,855.00
226,052.64
Interest Income
4,982.00
3,950.00
8,330.00
961.00
890.00
Interest Expense
28,069.00
23,748.00
8,218.00
10,179.00
3,754.00
Net Interest Income
-25,434.00
-19,798.00
112.00
-9,218.00
-2,864.00
EBIT
236,014.00
217,464.00
168,590.00
219,915.00
179,231.00
EBITDA
340,122.00
413,707.00
348,549.00
397,206.00
179,231.00
Reconciled Cost of Revenue
421,352.00
395,707.00
379,610.00
340,649.00
282,186.00
Reconciled Depreciation
104,108.00
196,243.00
179,959.00
177,291.00
158,354.00
Net Income from Continuing Operation Net Minority Interest
140,867.00
127,644.00
103,658.00
136,855.00
116,408.00
Total Unusual Items Excluding Goodwill
-79,470.00
-79,470.00
-80,701.00
-182,879.00
-159,032.00
Total Unusual Items
-79,470.00
-79,470.00
-80,701.00
-182,879.00
-158,871.00
Normalized EBITDA
419,592.00
493,177.00
429,250.00
397,206.00
338,102.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-25,474.58
-25,907.22
-25,501.52
--
-49,548.36
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0QMV.IL Straumann Holding AG
117.65
-1.35%
UTMD Utah Medical Products, Inc.
60.91
-0.02%
AFX.DE Carl Zeiss Meditec AG
46.36
-1.28%
WST West Pharmaceutical Services, Inc.
331.73
-1.54%
BLCO Bausch + Lomb Corporation
17.76
-1.77%
ALC Alcon Inc.
83.41
-0.36%
RMD ResMed Inc.
233.82
-1.00%
BDX Becton, Dickinson and Company
233.67
-0.32%
ALGN Align Technology, Inc.
212.12
-1.51%
ISRG Intuitive Surgical, Inc.
547.47
+0.63%